Previous close | 0.0500 |
Open | 0.0800 |
Bid | 0.0000 |
Ask | 0.3500 |
Strike | 125.00 |
Expiry date | 2024-06-14 |
Day's range | 0.0600 - 0.0800 |
Contract range | N/A |
Volume | |
Open interest | 67 |
Over the past year, many DexCom, Inc. ( NASDAQ:DXCM ) insiders sold a significant stake in the company which may have...
DexCom (DXCM) announces the direct connectivity of its G7 CGM system to Apple Watch for users in the United States, the UK, and Ireland.
SAN DIEGO, June 05, 2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch* in the United States. Dexcom G7 is the first and only CGM available with Direct to Apple Watch, offering users the freedom and convenience of real-time glucose readings on their wrist even when their iPhone isn’t with them.†